4CQK | pdb_00004cqk

PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate

PIO is a Ligand Of Interest in 4CQK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CQK_PIO_N_1048	97%	51%	0.068	0.983	0.94	0.97	2	2	3	0	100%	1
4CQK_PIO_D_1048	95%	50%	0.077	0.983	1.03	0.92	2	4	16	0	100%	1
4CQK_PIO_J_1048	95%	42%	0.077	0.981	1.03	1.21	3	4	10	0	100%	1
4CQK_PIO_H_1048	95%	40%	0.075	0.977	1.01	1.32	2	6	16	0	100%	1
4CQK_PIO_K_1048	94%	38%	0.078	0.978	1.04	1.38	2	5	9	0	100%	1
4CQK_PIO_A_1048	94%	41%	0.081	0.98	0.99	1.31	2	6	9	0	100%	1
4CQK_PIO_I_1048	94%	47%	0.078	0.975	0.97	1.09	3	3	10	0	100%	1
4CQK_PIO_G_1048	92%	45%	0.088	0.978	1.02	1.11	2	6	22	0	100%	1
4CQK_PIO_M_1048	88%	45%	0.089	0.966	1.02	1.12	2	6	5	0	100%	1
4CQK_PIO_C_1048	88%	38%	0.098	0.974	1.07	1.33	4	5	5	0	100%	1
4CQK_PIO_F_1048	87%	47%	0.094	0.966	1.04	1.02	2	4	6	0	100%	1
4CQK_PIO_E_1048	86%	45%	0.103	0.972	1.06	1.08	3	3	11	0	100%	1
4CQK_PIO_B_1048	86%	42%	0.098	0.965	1.06	1.18	3	6	10	0	100%	1
4CQK_PIO_L_1048	84%	40%	0.104	0.967	1.06	1.27	2	7	4	0	100%	1
5VYP_PIO_N_101	68%	46%	0.158	0.971	1.17	0.91	6	2	4	0	100%	1
6CS9_PIO_B_101	59%	44%	0.131	0.911	1.21	0.96	6	2	6	0	100%	1
4KFM_PIO_A_401	51%	61%	0.078	0.891	0.65	0.85	-	-	0	0	66%	1
5KUM_PIO_A_401	35%	41%	0.159	0.928	0.74	1.52	-	8	0	0	55%	1
3SPG_PIO_A_400	35%	40%	0.214	0.936	1.16	1.18	2	4	0	0	81%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.